DNA Friday

Discussion in 'Trading' started by switze22, Mar 10, 2008.

  1. Genentech is having their analyst meeting with earnings/guidance announcement on Friday.

    With Avastin approved for Breast Cancer, this will prob lead to increase in guidance.

    Just wanted to let you know and see what you think
  2. These are my thoughts:

    Friday: Earnings, Guidance, Analysts

    Earnings: Hit top end of earnings, or beat earnings

    Guidance: Guidance will be positive and upbeat with Avastin's approval

    Analysts: Upgrades from those who haven't already

    Combine these with potential talks about other drug trials and Avastin
    sales, and I say we should have a GREAT day.

    And just to sweeten the deal, Cramer talked about DNA tonight for like
    10 minutes and he will get his watchers to buy, pushing the stock up
    hopefully up and up even BEFORE Friday.

    I got lots of March80Calls.

    What do you all think?